K. Peony Yu

2015

In 2015, K. Peony Yu earned a total compensation of $2.8M as Chief Medical Officer at FibroGen, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$274,788
Option Awards$1,124,849
Salary$445,000
Stock Awards$951,137
Other$16,530
Total$2,812,304

Yu received $1.1M in option awards, accounting for 40% of the total pay in 2015.

Yu also received $274.8K in non-equity incentive plan, $445K in salary, $951.1K in stock awards and $16.5K in other compensation.

Rankings

In 2015, K. Peony Yu's compensation ranked 3,399th out of 13,638 executives tracked by ExecPay. In other words, Yu earned more than 75.1% of executives.

ClassificationRankingPercentile
All
3,399
out of 13,638
75th
Division
Manufacturing
1,235
out of 5,187
76th
Major group
Chemicals And Allied Products
448
out of 1,857
76th
Industry group
Drugs
357
out of 1,531
77th
Industry
Pharmaceutical Preparations
284
out of 1,179
76th
Source: SEC filing on April 24, 2017.

Yu's colleagues

We found three more compensation records of executives who worked with K. Peony Yu at FibroGen in 2015.

2015

Thomas Neff

FibroGen

Chief Executive Officer

2015

Frank Valone

FibroGen

Chief Medical Officer

2015

Pat Cotroneo

FibroGen

Chief Financial Officer

News

You may also like